Resolution of drug-related problems in home care patients through a pharmacy referral service

American Journal of Health-System Pharmacy

Volumn 60, Issue 9, 2003, Pages 905-910

  Triller, Darren M ^a   Clause, Steven L ^a   Briceland, Laurie L ^a   Hamilton, Robert A ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Clinical pharmacists; Clinical pharmacy; Drugs, adverse reactions; Health care; Interventions; Pharmaceutical services

Indexed keywords

DRUG; NON PRESCRIPTION DRUG;

ADVERSE DRUG REACTION; ARTICLE; CAREGIVER; CLINICAL PHARMACY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG CHOICE; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG OVERDOSE; FALLING; HEALTH CARE COST; HEALTH CARE POLICY; HIGH RISK POPULATION; HOME CARE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL RECORD; NURSE; PAIN; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PATIENT REFERRAL; PATIENT SELECTION; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN; POLYPHARMACY; PRIORITY JOURNAL; TELEPHONE; UNITED STATES;

EID: 0037632765     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.9.905     Document Type: Article

References (38)

1. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995; 155:1949-56.
2. McGoldrick MD, Bailie GR. Nonnarcotic analgesics: prevalence and estimated economic impact of toxicities. Ann Pharmacother. 1997; 31:221-7.
3. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002; 36:1331-6.
4. Guralnik JM, Alecxih L, Branch LG et al. Medical and long-term care costs when older persons become dependent. Am J Public Health. 2002; 92:1244-5.
5. Gilman BH. Hospital response to DRG refinements: the impact of multiple reimbursement incentives on inpatient length of stay. Health Econ. 2000; 9:277-94.
6. Rosenberg AL, Zimmerman JE, Alzola C et al. Intensive care unit length of stay: recent changes and future challenges. Crit Care Med. 2000; 28:3465-73.
7. Munson ML. Characteristics of elderly home health care users: data from the 1996 National Home and Hospice Care Survey. Adv Data. 1999; Dec 22:1-11.
8. Gray SL, Mahoney JE, Blough DK. Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 1999; 33:1147-53.
9. Simons LA, Tett S, Simons J et al. Multiple medication use in the elderly. Use of prescription and nonprescription drugs in an Australian community setting. Med J Aust. 1992; 157:242-6.
10. Sullivan DH, Walls RC. Impact of nutritional status on morbidity in a population of geriatric rehabilitation patients. J Am Geriatr Soc. 1994; 42:471-7.
11. Kaufman J, Dhakal M, Patel B et al. Community-acquired acute renal failure. Am J Kidney Dis. 1991; 17:191-8.
12. Heerdink ER, Leufkens HG, Herings RM et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med. 1998; 158:1108-12.
13. Whelton A. Renal effects of over-the-counter analgesics. J Clin Pharmacol. 1995; 35:454-63.
14. Whelton A. Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and nonNSAID analgesics. Am J Ther. 2000; 7:63-74.
15. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med. 2000; 160:777-84.
16. Medicare program: solicitation for proposals for the demonstration project for disease management for severely chronically ill Medicare beneficiaries with congestive heart failure, diabetes, and coronary heart disease. Fed Reg. 2002; 67:8267-70.
17. Olmstead v. L.C. 138 F.3d 893 (U.S. Supreme Court 1999 Jun 22).
18. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health-Syst Pharm. 1997; 54:554-8.
19. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-70.
20. Guerrero RM. The role of the clinical specialist in reengineered pharmacy departments. Pharm Pract Manag Q. 1997; 17:54-63.
21. Ogden JE, Muniz A, Patterson AA et al. Pharmaceutical services in the Department of Veterans Affairs. Am J Health-Syst Pharm. 1997; 54:761-5.
22. Alsuwaidan S, Billups SJ, Carter BL. Characteristics of ambulatory care clinics in Veterans Affairs medical centers. IMPROVE Investigators. Impact of managed pharmaceutical care on resource utilization and outcomes in Veterans Affairs medical centers. Am J Health-Syst Pharm. 1998; 55:68-72.
23. Rind DM, Safran C, Phillips RS et al. Effect of computer-based alerts on the treatment and outcomes of hospitalized patients. Arch Intern Med. 1994; 154:1511-7.
24. Leape LL, Brennan TA, Laird N et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991; 324:377-84.
25. Leape LL, Bates DW, Cullen DJ et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995; 274:35-43.
26. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995; 274:29-34.
27. American Society of Health-System Pharmacists. ASHP guidelines on the pharmacist's role in home care. Am J Health-Syst Pharm. 2000; 57:1252-7.
28. Denham MJ, Barnett NL. Drug therapy and the older person: role of the pharmacist. Drug Saf. 1998; 19:243-50.
29. Stewart S, Vandenbroek AJ, Pearson S et al. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Arch Intern Med. 1999; 159:257-61.
30. Dvorak SR, McCoy RA, Voss GD. Continuity of care from acute to ambulatory care setting. Am J Health-Syst Pharm. 1998; 55:2500-4.
31. Hsia Der E, Rubenstein LZ, Choy GS. The benefits of in-home pharmacy evaluation for older persons. J Am Geriatr Soc. 1997; 45:211-4.
32. Triller DM, Hamilton RA, Waite NM et al. Impact of pharmacist visits on heart failure patients receiving home health care services. Paper presented at Annual Meeting of the American College of Clinical Pharmacy. Tampa, FL; 2001 Oct.
33. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1999:117.
34. Strand LM, Morley PC, Cipolle RJ et al. Drug-related problems: their structure and function. DICP Ann Pharmacother. 1990; 24:1093-7.
35. Gattis WA, Hasselblad V, Whellan DJ et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study. Arch Intern Med. 1999; 159:1939-45.
36. Whellan DJ, Gaulden L, Gattis WA et al. The benefit of implementing a heart failure disease management program. Arch Intern Med. 2001; 161:2223-8.
37. 42 U.S.C. Sec § 1395x.
38. Audette CM, Triller DM, Hamilton RA et al. Classification of drug-related problems in the home care environment. Am J Health-Syst Pharm. 2002; 59:2407-9.